210 related articles for article (PubMed ID: 26344802)
1. Calls for caution in genome engineering should be a model for similar dialogue on pandemic pathogen research.
Lipsitch M; Esvelt K; Inglesby T
Ann Intern Med; 2015 Nov; 163(10):790-1. PubMed ID: 26344802
[No Abstract] [Full Text] [Related]
2. Genome editing: The domestication of Cas9.
Urnov F
Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037
[No Abstract] [Full Text] [Related]
3. Bioethics. Embryo engineering alarm.
Vogel G
Science; 2015 Mar; 347(6228):1301. PubMed ID: 25792311
[No Abstract] [Full Text] [Related]
4. Gene drive overdrive.
Nat Biotechnol; 2015 Oct; 33(10):1019-21. PubMed ID: 26448078
[No Abstract] [Full Text] [Related]
5. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
Doudna JA; Sontheimer EJ
Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
[No Abstract] [Full Text] [Related]
6. Biotechnology. A prudent path forward for genomic engineering and germline gene modification.
Baltimore D; Berg P; Botchan M; Carroll D; Charo RA; Church G; Corn JE; Daley GQ; Doudna JA; Fenner M; Greely HT; Jinek M; Martin GS; Penhoet E; Puck J; Sternberg SH; Weissman JS; Yamamoto KR
Science; 2015 Apr; 348(6230):36-8. PubMed ID: 25791083
[TBL] [Abstract][Full Text] [Related]
7. Bioethics. Embryo engineering study splits scientific community.
Kaiser J; Normile D
Science; 2015 May; 348(6234):486-7. PubMed ID: 25931531
[No Abstract] [Full Text] [Related]
8. Treading the Line Between Sensational and Groundbreaking Science.
Scott C
Am J Bioeth; 2015; 15(12):1-2. PubMed ID: 26632353
[No Abstract] [Full Text] [Related]
9. Eugenics lurk in the shadow of CRISPR.
Pollack R
Science; 2015 May; 348(6237):871. PubMed ID: 25999496
[No Abstract] [Full Text] [Related]
10. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
[TBL] [Abstract][Full Text] [Related]
11. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
Li H; Qiu S; Song H
Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas3 Adds a Power Saw to the Toolbox for Human Genome Engineering.
Hatoum-Aslan A
CRISPR J; 2019 Jun; 2():150-152. PubMed ID: 31225749
[No Abstract] [Full Text] [Related]
13. [Not Available].
Nau JY
Rev Med Suisse; 2016 Apr; 12(513):714-5. PubMed ID: 27197328
[No Abstract] [Full Text] [Related]
14. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
16. Genome modification by CRISPR/Cas9.
Ma Y; Zhang L; Huang X
FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
[TBL] [Abstract][Full Text] [Related]
17. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
[TBL] [Abstract][Full Text] [Related]
18. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
19. Germline gene therapy: We're ready.
Miller HI
Science; 2015 Jun; 348(6241):1325. PubMed ID: 26089502
[No Abstract] [Full Text] [Related]
20. Genetic screens and functional genomics using CRISPR/Cas9 technology.
Hartenian E; Doench JG
FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
